Pembrolizumab Monoclonal Antibody from Mexico
Pembrolizumab (Keytruda) is a humanized IgG4 monoclonal antibody blocking PD-1 for immunotherapy in melanoma and lung cancer. HTS 3002.13.0010 for unmixed biotech monoclonal antibodies regulating immunology. Supplied in bulk, non-retail.
Duty Rate — Mexico → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Align with FDA's RPDR for real-time import status tracking
• Include ADCC assay data for potency verification